Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Schorb

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2012
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphomaBenjamin Kasenda, Vanessa Haug, Elisabeth Schorb, et al.
Journal of Neurology|March 8, 2018
The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosisTilman Hottenrott, Elisabeth Schorb, Kristina Fritsch, et al.
Annals of Hematology|July 13, 2014
Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host diseaseDominik Bettinger, Elisabeth Schorb, Daniela Huzly, et al.
Haematologica|January 23, 2025
Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaJulia Wendler, Richard I Lewis, Alexandra Kutilina, et al.
European Journal of Pediatrics|March 28, 2007
Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemiaKarl Otfried Schwab, Jürgen Doerfer, Andreas Krebs, et al.
Hematological Oncology|June 29, 2023
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapsePaola Ghione, Katharine L Lewis, Sabela Bobillo, et al.
Cancers|February 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous SystemJulia Wendler, Benjamin Kasenda, Eliza M Lauer, et al.
BMC Cancer|April 22, 2016
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix)Elisabeth Schorb, Juergen Finke, Andrés J M Ferreri, et al.
BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.
Cancers|December 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS LymphomaLisa K Isbell, Annika Vreden, Gabriele Ihorst, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2012
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphomaBenjamin Kasenda, Vanessa Haug, Elisabeth Schorb, et al.
Journal of Neurology|March 8, 2018
The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosisTilman Hottenrott, Elisabeth Schorb, Kristina Fritsch, et al.
Annals of Hematology|July 13, 2014
Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host diseaseDominik Bettinger, Elisabeth Schorb, Daniela Huzly, et al.
Haematologica|January 23, 2025
Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaJulia Wendler, Richard I Lewis, Alexandra Kutilina, et al.
European Journal of Pediatrics|March 28, 2007
Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemiaKarl Otfried Schwab, Jürgen Doerfer, Andreas Krebs, et al.
Hematological Oncology|June 29, 2023
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapsePaola Ghione, Katharine L Lewis, Sabela Bobillo, et al.
Cancers|February 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous SystemJulia Wendler, Benjamin Kasenda, Eliza M Lauer, et al.
BMC Cancer|April 22, 2016
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix)Elisabeth Schorb, Juergen Finke, Andrés J M Ferreri, et al.
BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.
Cancers|December 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS LymphomaLisa K Isbell, Annika Vreden, Gabriele Ihorst, et al.
Pageof 5